Ophthotech Launching Human Study of Emerging Therapy for Stargardt Disease

[vc_row][vc_column][vc_column_text]  Reprinted with permission from the Foundation Fighting Blindness Blog Ophthotech, a biopharmaceutical company developing therapies for eye diseases, has enrolled the first patient in its Phase 2b clinical trial of Zimura® for people with Stargardt disease caused by mutations in the gene ABCA4. The 120-participant study will be taking place at more than 30 sites. Data and… Continue reading Ophthotech Launching Human Study of Emerging Therapy for Stargardt Disease

Two Blind Brothers Support Research to End Blindness

[vc_row][vc_column][vc_column_text]Bradford and Bryan Manning were diagnosed with Stargardt’s disease in childhood.  The disorder caused gradual loss of their central vision, and it also gave them a mission:  To raise awareness and help others with eye diseases. They decided to develop a clothing company and donate the earnings to support research to end blindness.  Now called… Continue reading Two Blind Brothers Support Research to End Blindness